330
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery

, , &
Pages 117-128 | Published online: 25 Feb 2010

References

  • LowesMABowcockAMKruegerJGPathogenesis and therapy of psoriasisNature200744586687217314973
  • SuYHFangJYDrug delivery and formulations for the topical treatment of psoriasisExpert Opin Drug Deliv2008523524918248321
  • VakirlisEKastanisAIoannidesDCalcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgarisTher Clin Risk Manage20084141148
  • WitmanPMTopical therapies for localized psoriasisMayo Clin Proc20017694394911560307
  • van der KerkhofPCMCambazardFHutchinsonPEThe effect of addition of calcipotriol ointment (50 μg/g) to acitretin therapy in psoriasisBr J Dermatol199813884899536227
  • Ben-ShabatSBenistyRWormserUSintovACVitamin D3-based conjugates for topical treatment of psoriasis: synthesis, antiproliferative activity, and cutaneous penetration studiesPharm Res200522505715771229
  • BowmanPHMaloneyJEKooJYCombination of calcipotriene (Dovonex®) ointment and tazarotene (Tazorac®) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot studyJ Am Acad Dermatol20024690791312063489
  • FoghKKragballeKNew vitamin D analogs in psoriasisCurr Drug Target Inflamm Allergy20043199204
  • AdachiYUchidaNMatsuoTHorioTClinical effect of vitamin D3 analogues is not inactivated by subsequent UV exposurePhotodermatol Photoimmunol Phatomed2008241618
  • PoplePVSinghKKDevelopment and evaluation of topical formulation containing solid lipid nanoparticles of vitamin AAAPS Pharm Sci Tech20067E1E7
  • MandawgadeSDPatravaleVBDevelopment of SLNs from natural lipids: application to topical delivery of tretinoinInt J Pharm200836313213818657601
  • MüllerRHPetersenRDHommossAPardeikeJNanostructured lipid carriers (NLC) in cosmetic dermal productsAdv Drug Deliv Rev20075952253017602783
  • de JongEMGJMørkNJSeijgerMMBThe combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trialBr J Dermatol200314831832512588386
  • DemerjianMMaoMQChoiEHTopical treatment with thiazolidinediones, activators of peroxisome proliferators-activated receptor-γ, normalizes epidermal homeostasis in a murine hyperproliferative disease modelExp Dermatol20061515416016480422
  • IlicLGowrishankarTRVaughanTEHerndonTOWeaverJCSpatially constrained skin electroporation with sodium thiosulfate and urea creates transdermal microconduitsJ Control Release19996118520210469915
  • JenningVThünemannAFGohlaSHCharacterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipidsInt J Pharm200019916717710802410
  • FangJYFangCLLiuCHSuYHLipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)Eur J Pharm Biopharm20087063364018577447
  • PugliaCBlasiPRizzaLLipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigationInt J Pharm200835729530418343059
  • WissingSAMüllerRHSolid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetrationJ Control Release20028122523312044563
  • WeyenbergWFilevPVan den PlasDCytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal applicationInt J Pharm200733729129817300887
  • JoresKHaberlandAWartewigSMäderKMehnertWSolid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopyPharm Res2005221887189716132349
  • Lombardi BorgiaSRegehlyMSivaramakrishnanRLipid nanoparticles for skin penetration enhancement – correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopyJ Control Release200511015116316297487
  • BaroliBLópez-QuintelaMADelgado-CharroMBFaddaAMBlanco-MéndezJMicroemulsions for topical delivery of 8-methoxsalenJ Control Release20006920921811018558
  • DubeyVMishraDDuttaTNaharMSarafDKJainNKDermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomesJ Control Release200712314815417884226
  • VenkateswarluVManjunathKPreparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticlesJ Control Release20049562763815023472
  • MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm20005016117710840199
  • JenningVSchäfer-KortingMGohlaSVitamin A-loaded solid lipid nanoparticles for topical use: drug release propertiesJ Control Release20006611512610742573
  • BunjesHDrechslerMKochMHJWestesenKIncorporation of the model drug ubidecarenone into solid lipid nanoparticlesPharm Res20011828729311442266
  • HuFQJiangSPDuYZYuanHYeYQZengSPreparation and characteristics of monostearin nanostructured lipid carriersInt J Pharm2006314838916563671
  • MüllerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliv Rev200254S131S15512460720
  • ChenHChangXDuDPodophyllotoxin-loaded solid lipid nanoparticles for epidermal targetingJ Control Release200611029630616325954
  • KüchlerSRadowskiMRBlaschkeTNanoparticles for skin penetration enhancement – a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticlesEur J Pharm Biopharm20097124325018796329
  • SoutoEBAlmeidaAJMüllerRHLipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effectsJ Biomed Nanotechnol20073317331
  • BourkeJFBerth-JonesJHutchinsonPEOcclusion enhances the efficacy of topical calcipotriol in the treatment of psoriasis vulgarisClin Exp Dermatol1993185045068252786
  • NielsenPGCalcipotriol or clobetasol propionate occluded with a hydrocolloid dressing for treatment of nummular psoriasisActa Derm Venereol1993733947904413
  • Alvarez-FigueroaMJBlanco-MéndezJTransdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsionsInt J Pharm2001215576511250092
  • Schäfer-KortingMMehnertWKortingHLipid nanoparticles for improved topical application of drugs for skin diseasesAdv Drug Deliv Rev20075942744317544165
  • KoganAGartiNMicroemulsions as transdermal drug delivery vehiclesAdv Colloid Interf Sci2006123–126369385
  • WongTWChenCHHuangCCLinCDHuiSWPainless electroporation with a new needle-free microelectrode array to enhance transdermal drug deliveryJ Control Release200611055756516356576
  • ZhaoKSinghJIn vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanolJ Control Release19996235936610528073
  • SerupJAgnerTColorimetric quantification of erythema – a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetryClin Exp Dermatol1990152672722208776